Michael S Toss Selected Research

Michael S Toss Research Topics

Disease

44	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2018
25	Neoplasms (Cancer) 12/2023 - 11/2018
17	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 04/2017
9	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2019
8	Breast Ductal Carcinoma 01/2022 - 12/2018
7	Ovarian Neoplasms (Ovarian Cancer) 06/2023 - 01/2019
6	Ovarian Epithelial Carcinoma 07/2022 - 01/2019
6	Necrosis 01/2020 - 01/2018
5	Triple Negative Breast Neoplasms 12/2023 - 01/2020
4	Carcinogenesis 10/2023 - 01/2019
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2022
4	Disease Progression 11/2022 - 10/2019
4	Carcinoma (Carcinomatosis) 01/2021 - 10/2019
3	Lymphatic Metastasis 12/2021 - 11/2018
2	Hypoxia (Hypoxemia) 01/2022 - 10/2019
1	Monosomy 10/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Nijmegen Breakage Syndrome-Like Disorder 12/2020
1	Residual Neoplasm 11/2019
1	Margins of Excision 11/2019
1	Mammary Paget's Disease 11/2019
1	Genomic Instability 01/2019
1	Ductal Carcinoma 01/2019
1	Lobular Carcinoma 01/2019

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2018
13	Messenger RNA (mRNA)IBA 09/2023 - 11/2018
8	Phenobarbital (Luminal)FDA Link 12/2023 - 09/2020
8	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2019
6	PlatinumIBA 07/2022 - 01/2019
5	Hormones (Hormone)IBA 11/2022 - 01/2019
4	Estrogen ReceptorsIBA 01/2023 - 01/2018
4	RNA (Ribonucleic Acid)IBA 11/2022 - 11/2020
3	Eosine Yellowish-(YS) (Eosin)IBA 12/2023 - 01/2018
3	human ERBB2 proteinIBA 12/2023 - 12/2020
3	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 12/2020
3	olaparibIBA 01/2020 - 12/2018
2	Hematoxylin (Haematoxylon)IBA 12/2023 - 01/2018
2	6- (4- hydroxyphenyl)- 2- thioxo- 2,3- dihydro- 4(1H)- pyrimidinoneIBA 06/2023 - 07/2022
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 10/2022
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 01/2023
2	AndrogensIBA 10/2022 - 01/2022
2	MethyltransferasesIBA 10/2022 - 01/2022
2	6-methyladenineIBA 10/2022 - 01/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 01/2019
2	CollagenIBA 10/2019 - 10/2019
1	Caveolin 1IBA 10/2023
1	CalciumIBA 10/2023
1	Small Interfering RNA (siRNA)IBA 10/2023
1	Cyclin B1IBA 04/2023
1	Long Noncoding RNAIBA 03/2023
1	Replication Protein AIBA 03/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 12/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2022
1	N-methyladenosineIBA 10/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2022
1	Ubiquitin-Conjugating EnzymesIBA 04/2022
1	UbiquitinIBA 04/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2022
1	Protein-Arginine DeiminasesIBA 01/2022
1	Cyclin B2IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Aurora Kinase AIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	DNA HelicasesIBA 11/2021
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 11/2021
1	DNA Polymerase beta (DNA Polymerase IV)IBA 11/2021
1	Flap EndonucleasesIBA 07/2021
1	ParaffinIBA 04/2021
1	Formaldehyde (Formol)FDA Link 04/2021
1	Aldehyde Dehydrogenase 1 FamilyIBA 04/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 02/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	InterferonsIBA 01/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2020
1	Lipocalin-2IBA 02/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020
1	Retinoid X Receptor gammaIBA 10/2019
1	C.I. direct red 80IBA 10/2019
1	Hypoxia-Inducible Factor 1IBA 06/2019
1	Cathepsin AIBA 06/2019
1	AC133 AntigenIBA 04/2019
1	KinesinsIBA 01/2019
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	asparaginylendopeptidase (legumain)IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019

Therapy/Procedure

16	Therapeutics 01/2023 - 04/2017
5	Radiotherapy 01/2020 - 04/2017
4	Segmental Mastectomy (Lumpectomy) 11/2021 - 04/2017
3	Drug Therapy (Chemotherapy) 10/2022 - 11/2020
2	Neoadjuvant Therapy 01/2021 - 01/2021
1	Adjuvant Chemotherapy 10/2022
1	Castration 01/2022
1	Mastectomy (Mammectomy) 11/2019
1	Adjuvant Radiotherapy 10/2019